-- Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius -- -- National Reimbursement Payment Determination from CMS for its PoNS Controller Deferred to the Next Cycle -- NEWTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced t ...

JACKSON, Mich., Oct. 10, 2024 /PRNewswire/ -- CMS Energy announced today it will provide 2024 third quarter results along with a business and financial outlook at 9:30 a.m. EDT on Thursday, October 31, 2024. A webcast of the presentation will be available on CMS Energy's website, cmsenergy.com. An audio replay will be available approximately three hours after the webcast and will be archived for 30 days on CMS Energy's website in the "Investor Relations" section. CMS Energy (NYSE: CMS) is a Michigan-based e ...

NEW YORK and TOKYO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) ("HeartCore" or "the Company"), a leading enterprise software and data consulting services company based in Tokyo, announced its Content Management System ("CMS") platform has achieved top market share in sales value in Japan for nine consecutive years, according to ITR Corporation, an independent IT consulting and research firm. The report disclosed that HeartCore owns a leading 15.1% market share in Japan, wit ...

Designed to help dialysis organizations incorporate new treatments into their practices, TDAPA provides two years of reimbursement in addition to the ESRD bundled rate A HCPCS code has also been assigned to Vafseo to facilitate reimbursement at dialysis organizations CAMBRIDGE, Mass., Oct. 10, 2024 /PRNewswire/ -- Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the Center for Medicare & Med ...

NEW YORK and TOKYO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) ("HeartCore" or "the Company"), a leading enterprise software and data consulting services company based in Tokyo, announced it has been awarded a new contract from Fourmix Co., Ltd. ("Fourmix"), a Japanese IT and web development company. Partnership Logo Through this contract, HeartCore will implement its CMS platform to enhance Fourmix's web development and digital marketing domain capabilities. HeartCore will ...

文章核心观点 - CMS Energy公司正在系统性地进行投资,以提升其运营并为客户提供优质服务 [1] - 公司正在扩大可再生电力组合,同时淘汰燃煤发电机组 [1] - 但公司仍面临一些不利因素,如关闭煤灰固体废物处理设施的相关成本以及商品价格波动 [1] 有利因素 - CMS Energy正大幅投资于基础设施改造、更换和清洁电力生产,以提高客户满意度和提升运营弹性 [2] - 公司计划在2024-2028年期间进行170亿美元的资本支出 [2] - 公司计划到2040年安装约8,000兆瓦的太阳能发电,并在2024年开始部署电池储能,到2027年达到75兆瓦,2040年达到550兆瓦 [2] - 公司还计划在前D.E. Karn燃煤发电厂建设一个85兆瓦的太阳能电站,预计2026年投入运营 [2] - 公司正在加强电网的弹性和可靠性,以减少客户停电,保护基础设施免受极端天气影响,并促进电力行业向清洁能源转型 [3] 不利因素 - 尽管公司的发电设施已安装多项污染控制措施,但随着碳排放规定日趋严格,公司仍面临一定风险,截至2023年12月31日,公司约20%的总发电来自煤炭 [4] - 为遵守相关法规,公司预计需在2024-2028年间投资2.38亿美元用于煤灰固体废物处理设施的开发、运营和关闭 [4] - 公司并未完全对其所有业务进行商品价格波动的套期保值,这可能会对其经营业绩产生负面影响 [4] 股价走势 - 过去3个月,CMS股价上涨18.8%,优于行业12.8%的涨幅 [5]

TI AND FOR 1 11:10 THE HD imantsu With the recent rise in the utility segment valuations as investors prepare for the strong potential of lower competitive interest rates, CMS Energy Co (NYSE:CMS) stock price has been strong. This has led to an overabundance of "Hold" recommendations for CMS stock. However, for long-term investors, CMS should be viewed as a highquality selection, both in earnings and dividend production and, more importantly, in its supportive regulatory background. I do not own the common ...

CLEVELAND, Ohio, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Centers for Medicare and Medicaid Services (CMS) has granted a product-specific procedure code ICD-10-PCS (International Classification of Diseases, 10th Revision, Procedure Coding System) for prademagene zamikeracel (pz-cel), Abeona's investigational autologous cell-based gene therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). If pz-cel receives U.S. marke ...

Multiple AI-powered features and seamless CMS integration influence Sitefinity Insight's status as a RealCDP™ BURLINGTON, Mass., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS), the trusted provider of AI-powered infrastructure software, today announced that Progress® Sitefinity Insight® customer data platform (CDP) has been certified by the Customer Data Platform (CDP) Institute as a RealCDP™ for meeting specific standards and capabilities that are essential for managing and utilizing customer da ...

文章核心观点 - NorthStar Clean Energy和通用汽车(GM)共同推出了Newport Solar项目,这是一个180MW的可再生能源项目,旨在为GM在密西西比独立系统运营商(MISO)地区的部分工厂提供可再生电力[2] - 该项目是NorthStar Clean Energy和GM之间不断创新和合作的成果,是GM实现其全球范围内减少范围2温室气体排放的关键举措之一[6] - 该项目预计每年可产生约41万兆瓦时的可再生能源,相当于为3万多个阿肯色州家庭提供电力[7] - 根据15年的可再生能源购买协议,该新设施产生的可再生能源证书相当于种植近500万棵树[8] 公司相关 - NorthStar Clean Energy是一家总部位于密歇根州的可再生能源公司,拥有和运营超过1500兆瓦的发电能力,包括密歇根、威斯康星和俄亥俄州的太阳能装置,德克萨斯州和俄亥俄州的风电资产,密歇根州的天然气和热电联产设施,以及密歇根州和北卡罗来纳州的生物质发电厂[9] - NorthStar Clean Energy计划将其唯一的燃煤电厂改造为一座60兆瓦的生物质发电厂,并配备二氧化碳捕集和储存(BECCS)技术,这将是美国首批BECCS项目之一[9] 行业相关 - 该项目是NorthStar Clean Energy和GM之间不断创新和合作的成果,体现了双方在可再生能源和可持续发展方面的共同承诺[4][5] - 该项目有助于GM实现其全球范围内减少范围2温室气体排放的目标,包括提高能源效率、采购可再生电力、使用更可靠的电力、增强供应可靠性,以及在不断扩大的可再生能源合作伙伴网络中进行重大全球投资[6]